Ermelinda Baiocco

National Cancer Institute

Papers

15

Total Citations

443

H-Index

11

About

Dr. Ermelinda Baiocco is a leading gynecologic oncologist whose research centers on advancing minimally invasive surgical techniques for endometrial and cervical cancer, with a particular focus on robotic surgery. Her work has fundamentally shaped the shift from traditional laparotomy to robotic-assisted approaches, demonstrating that these methods are not only feasible but also superior in obese and high-risk patient populations. Her landmark multi-institutional analysis (96 citations) established the safety and efficacy of robotic hysterectomy in obese patients with endometrial cancer, a critical contribution given the rising rates of obesity. Dr. Baiocco is also a pioneer in robotic single-site surgery, authoring several of the earliest studies (59, 30, 28, and 25 citations) that validated this technique for reducing surgical morbidity and improving cosmetic outcomes. Her comparative studies, including a 2015 analysis (80 citations), consistently show that robotic surgery offers equivalent oncologic outcomes to laparoscopy and open surgery, with reduced blood loss and shorter hospital stays. With over 400 total citations, her work has been instrumental in establishing robotic surgery as a standard of care in gynecologic oncology, particularly for early-stage endometrial cancer and locally advanced cervical cancer after neoadjuvant chemotherapy.

Research Focus

Key Achievements

11
H-Index
15
Papers
443
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis
96 citations · 2018
📈 Most Prolific Year: 2025 (5 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: National Cancer Institute

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago